BREA, NASDAQ #IPO #Shares Pricing Brera Holdings PLC Announces Pricing of Initial Public Offering January 27, 2023 10:15 EST NEW YORK, DUBLIN and MILAN, Jan. 27, 2023 (GLOBE NEWSWIRE) — Brera Holdings PLC (“Brera Holdings” or the “Company”) today announced the pricing of its initial public offering of 1,500,000 Class B Ordinary Shares at a price to the public of $5.00 per share for a total of $7,500,000 No Comments
MOVE, NASDAQ #Shares Pricing #Trending News Movano Health Prices $6.5 Million Public Offering January 27, 2023 08:00 EST PLEASANTON, Calif., Jan. 27, 2023 /PRNewswire/ — Movano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring, today announced that it has priced a $6.5 million underwritten public offering of 4,644,000 shares of its common stock and No Comments
NASDAQ, WGS #Featured #Shares Pricing #Trending News GeneDx Holdings Announces Pricing Of A $150 Million Underwritten Public Offering Of Class A Common Stock And Concurrent Registered Direct Offering January 27, 2023 06:00 EST STAMFORD, Conn., Jan. 27, 2023 (GLOBE NEWSWIRE) — GeneDx Holdings Corp. (Nasdaq: WGS) today announced the pricing of offerings for an aggregate of 428,571,429 shares of its Class A common stock at a public offering price of $0.35 per share (the “Offerings”). The Offerings consist of an underwritten public offering (the No Comments
NASDAQ, PBLA #Shares Pricing #Trending News Panbela Announces Pricing of Approximately $15 Million Public Offering January 26, 2023 08:41 EST MINNEAPOLIS, Jan. 26, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), (“Panbela” or the “Company”), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced the pricing of a public offering of (i) 6,675,000 shares of its common stock No Comments
NYSE, SNX #Shares Pricing #Trending News TD SYNNEX Announces Pricing of Secondary Public Offering of Common Stock and Concurrent Share Repurchase January 25, 2023 23:58 EST FREMONT, Calif. & CLEARWATER, Fla.–(BUSINESS WIRE)–TD SYNNEX Corporation (NYSE: SNX) (“TD SYNNEX” or the “Company”) today announced the pricing of a secondary public offering of 4,500,000 shares of its common stock at a price to the public of $97.00 per share. All of the shares in the offering are No Comments
FNA, NYSE #Shares Pricing #Trending News Paragon 28, Inc. Announces Pricing of Public Offering January 25, 2023 22:47 EST ENGLEWOOD, Colo.–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) (“Paragon”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, announced today the pricing of the previously announced underwritten public offering of 6,500,000 shares of its common stock at a public offering price of $17.00 per share, No Comments
GLATF, OTC #Shares Pricing Global Atomic Announces Pricing of C$100 Million Public Offering of Units January 25, 2023 11:46 EST NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Jan. 25, 2023 (GLOBE NEWSWIRE) — Global Atomic Corporation (“Global Atomic” or the “Company”) (TSX: GLO, FRANKFURT: G12) today announced the size and pricing of its previously announced overnight marketed public offering (the No Comments
KOPN, NASDAQ #Shares Pricing #Trending News Kopin Announces Pricing of Public Offering January 25, 2023 09:05 EST WESTBOROUGH, Mass.–(BUSINESS WIRE)–Kopin Corporation (Nasdaq: KOPN), a leading provider of application-specific optical solutions for defense, enterprise, industrial, and consumer products, today announced that it has priced an underwritten public offering of 14,000,000 shares of its common stock at a public offering price of $1.00 per share. In addition, in No Comments
JSPR, NASDAQ #Shares Pricing #Syndromes #Trending News Jasper Therapeutics Announces Pricing of $90 Million Public Offering of Common Stock January 25, 2023 08:00 EST REDWOOD CITY, Calif., Jan. 25, 2023 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”), a biotechnology company focused on developing novel antibody therapies targeting c-Kit (CD117) to address diseases such as chronic spontaneous urticaria and lower to intermediate risk myelodysplastic syndromes (MDS) as well as novel stem cell No Comments
NASDAQ, PACB #Shares Pricing #Trending News Pacific Biosciences of California, Inc. Announces Pricing of Upsized Public Offering of Common Stock January 24, 2023 23:18 EST MENLO PARK, Calif., Jan. 24, 2023 /PRNewswire/ — Pacific Biosciences of California, Inc. (Nasdaq: PACB) (“PacBio”) today announced that it has priced its previously announced underwritten public offering of 17,500,000 shares of its common stock at a price to the public of $10.00 per share. PacBio has granted the No Comments
Scilex Holding Company Announces that its Majority Stockholder, Sorrento Therapeutics, Inc., has Issued an “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock 01/29/2023
STEER Announces a Proposed Transaction for an $18 Million Direct Investment Involving its Digital Restaurant Supply Business (B2B Marketplace) 01/23/2023
Ra Medical Systems Announces the Presentation of Clinical Data at the European Heart Rhythm Association Congress 01/23/2023
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Silvergate Capital Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – SI 01/23/2023